The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant ...

Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that the U.S. Food and Drug Administration (FDA) has ...

Teddi Mellencamp reveals the physical and emotional challenges of brain surgery and stage 4 cancer Read ahead to know about ...

Company management estimates that approximately 7,000 patients annually in the United States are affected by HER2-negative metastatic breast cancer with liver metastases and are candidates for ...

Delcath Systems, Inc. announced that it has received clearance from the FDA to initiate patient enrollment of a phase 2 clinical ...

When Roy Bradley was told he had cancer in his lungs and liver, his first thought was he couldn't face chemotherapy and ...

How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...

Exploring How Infection Following Removal Of A Body Part Caused Jiggly Caliente’s Death Stage 4 Cancer and Brain Surgery: What It Means Stage 4 cancer, or metastatic cancer, occurs when cancer ...

It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

Metastatic castration-resistant prostate cancer (mCRPC) is diagnosed by blood tests, imaging scans, and biopsies. Find out ...

Researchers from Memorial Sloan Kettering Cancer Center and the University of California, Los Angeles, identified that ...